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Background: To date, no study has explored the association between androgen levels and 25-hydroxyvitamin D
(25(OH)D) levels in Chinese men. We aimed to investigate the relationship between 25(OH)D levels and total and
free testosterone (T), sex hormone binding globulin (SHBG), estradiol, and hypogonadism in Chinese men.
Methods: Our data, which were based on the population, were collected from 16 sites in East China. There were
2,854 men enrolled in the study, with a mean (SD) age of 53.0 (13.5) years. Hypogonadism was defined as total
T <11.3 nmol/L or free T <22.56 pmol/L. The 25(OH)D, follicle-stimulating hormone, luteinizing hormone, total T,
estradiol and SHBG were measured using chemiluminescence and free T by enzyme-linked immune-sorbent assay.
The associations between 25(OH)D and reproductive hormones and hypogonadism were analyzed using linear
regression and binary logistic regression analyses, respectively.
Results: A total of 713 (25.0 %) men had hypogonadism with significantly lower 25(OH)D levels but greater BMI
and HOMA-IR. Using linear regression, after fully adjusting for age, residence area, economic status, smoking, BMI,
HOMA-IR, diabetes and systolic pressure, 25(OH)D was associated with total T and estradiol (P < 0.05). In the logistic
regression analyses, increased quartiles of 25(OH)D were associated with significantly decreased odds ratios of
hypogonadism (P for trend <0.01). This association, which was considerably attenuated by BMI and HOMA-IR,
persisted in the fully adjusted model (P for trend <0.01) in which for the lowest compared with the highest quartile
of 25(OH)D, the odds ratio of hypogonadism was 1.50 (95 % CI, 1.14, 1.97).
Conclusions: A lower vitamin D level was associated with a higher prevalence of hypogonadism in Chinese men.
This association might, in part, be explained by adiposity and insulin resistance and warrants additional
investigation.
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Vitamin D is a steroid hormone/vitamin that is present in
certain foods and may be generated by ultraviolet-B in the
skin. Vitamin D is hydroxylated in the liver to 25-hy-
droxy-vitamin D (25(OH)D), the primary form measured
to determine vitamin D status, and can be further hydrox-
ylated to its active form, 1,25-dihydroxy-vitamin D [1].* Correspondence: jensen@mayo.edu; luyingli2008@126.com
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creativecommons.org/publicdomain/zero/1.0/The classic picture of vitamin D function is the mainten-
ance of bone health and calcium/phosphorous metabol-
ism [2]. However, epidemiological studies have suggested
the impact of a pandemic of vitamin D deficiency on non-
skeletal functions, including certain cancers, autoimmune
diseases, infectious diseases, type 2 diabetes mellitus, neu-
rocognitive disorders, and mortality [3].
Vitamin D receptor (VDR) is present in the testis [4], pi-
tuitary gland [5] and hypothalamus [6]. Vitamin D is likely
involved in the regulation of gonadal function. Regarding
the association between vitamin D and reproduction, re-
plete vitamin D stores predicted reproductive success aftericle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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might have a detrimental impact on the in vitro
fertilization outcome [8]. In the USA and Europe, several
cross-sectional studies have detected that serum testoster-
one (T) levels and 25(OH)D levels were positively associ-
ated in men [1, 9, 10] and revealed a concordant seasonal
variation [1], whereas another study observed no concord-
ant seasonal variation [10]. Therefore, the association of
vitamin D with androgens and gonadal function in men
has not been fully clarified and has not been reported in
the general Chinese population.
We performed a large investigation in 2014, which is
referred to as Survey on Prevalence in East China for
Metabolic Diseases and Risk Factors (SPECT-China).
Using the data from the study, we aimed to determine
whether 25(OH)D was associated with the reproductive
hormones of the pituitary-testis axis and hypogonadism
that was based on total or free T. To the best of our
knowledge, the current analyses are the first to focus on
several likely explanatory factors contributing to the re-
lationship of 25(OH)D and hypogonadism, including
adiposity, insulin resistance and other metabolic factors.
Methods
Study population
SPECT-China is a population-based cross-sectional survey
on the prevalence of metabolic diseases and risk factors in
East China from February to June 2014. The registration
number is ChiCTR-ECS-14005052 (www.chictr.org). We
used a stratified cluster sampling method. The first sam-
pling level was based on rural and urban areas and the
second sampling level was based on an area’s economic
development. This study was performed in Shanghai,
Jiangxi Province and Zhejiang Province (three sites in
urban areas of Shanghai, one site in an urban area of
Jiangxi Province, three sites in rural areas in Shanghai,
three sites in rural areas in Zhejiang and six sites in rural
areas in Jiangxi Province) [11]. The inclusion criteria were
as follows: adults aged 18 years and older; Chinese citi-
zens; and living in their current residences for 6 months
or longer. Those who had severe communication prob-
lems or acute illnesses or were unwilling to participate
were excluded from the study.
A total of 7200 people participated in this investiga-
tion. The participants who had missing laboratory re-
sults (n =183) and missing questionnaire data (n =112)
and were younger than 18 years of age (n =6) were ex-
cluded from the study; a total of 6,899 subjects were en-
rolled in the SPECT-China study [11]. Among them,
there were 2940 men who did not receive vitamin D and
testosterone supplementation. Men with missing values
of 25(OH)D (n =1), total testosterone (n =7) and free
testosterone (n =78) were excluded from the study. Fi-
nally, this study included a total number of 2854 menwith a mean (SD) age of 53 (13) years. The study proto-
col was approved by the Ethics Committee of Shanghai
Ninth People’s Hospital, Shanghai Jiao Tong University
School of Medicine (approval number 2013 (86)). The
research was conducted according to the Declaration of
Helsinki. All of the participants provided written in-
formed consent before data collection.
Measurements
In every site, the same trained staff group completed
the questionnaire including information on demo-
graphic characteristics, medical history and lifestyle
risk factors, and they collected anthropometric data.
Current smoking was defined as having smoked at
least 100 cigarettes in one’s lifetime and currently
smoking cigarettes [12]. Body weight, height, and blood
pressure were measured using standard methods, as
previously described [12]. Body mass index (BMI) was
calculated as weight in kilograms divided by height in
meters squared.
The participants fasted for 8 h before the study. Fasting
blood samples were drawn between 0700 h and 1000 h.
The blood samples for the plasma glucose test were col-
lected in vacuum tubes with anticoagulant sodium fluoride
and centrifuged on the spot within 1 h after collection. The
blood samples were stored at −20 °C and were shipped by
air in dry ice within 2 to 4 h of collection to a central
laboratory, which is certified by the College of American
Pathologists. Glycated hemoglobin (HbA1c) was assessed
using high-performance liquid chromatography (MQ-
2000PT, China). The plasma glucose was measured using
Beckman Coulter AU680 (Germany). Insulin was detected
by chemiluminescence (Abbott i2000 SR, USA). The
25(OH)D, total T, estradiol (E2), follicle-stimulating hor-
mone (FSH) and luteinizing hormone (LH) were measured
using the immulite 2000 platform chemiluminescence im-
munoassays (Siemens, Germany) and sex hormone binding
globulin (SHBG) by electrochemiluminescence (Roche
Cobas E601, Switzerland). Free T was detected using en-
zyme-linked immunosorbent assay (Bio-Tek ELx808, USA).
The minimal detectable limit for hormones was as follows:
0.7 nmol/L (total T), 73.4 pmol/L (E2), and 0.1 IU/L (FSH
and LH). The inter-assay coefficients of variation were as
follows: 15 % (free T), 6.6 % (total T), 7.5 % (E2), 7 %
(SHBG), 4.5 % (FSH) and 6.0 % (LH). The intra-assay coef-
ficients of variation were as follows: 15 % (free T), 5.7 %
(total T), 7 % (SHBG), 6.2 % (E2), 3.8 % (FSH) and 4.9 %
(LH). Insulin resistance was estimated using the homeo-
static model assessment (HOMA-IR) index: [fasting insulin
(mIU/L) × fasting glucose (mmol/L)]/22.5.
Definition of variables and outcomes
Hypogonadism was defined as total T <11.3 nmol/L [13]
or free T <22.56 pmol/L [14] in men. Based on the







Age, yr 52 (14) 55 (13) <0.01
Metabolic factors
25(OH)D, nmol/L 43.7 (11.7) 42.6 (11.8) <0.01
HbA1c, % 5.4 (0.8) 5.6 (1.1) <0.01
Fasting glucose,
mmol/L
5.58 (1.24) 5.97 (1.76) <0.01
Fasting insulin,
pmol/L
35.6 (32.5) 48.9 (60.0) <0.01
HOMA-IR 1.31 (1.46) 1.96 (2.83) <0.01
Systolic pressure,
mmHg
131 (20) 134 (20) <0.01
BMI, kg/m2 24.2 (3.2) 25.4 (3.6) <0.01
Diabetes, % 10.7 19.9 <0.01
Sex-related hormones
Total T, nmol/L 17.8 (5.3) 11.2 (4.3) <0.01
Free T, pmol/L 54.0 (26.9) 33.0 (27.1) <0.01
E2, pmol/L 112.8 (64.5) 90.8 (55.9) <0.01
SHBG, nmol/L 48.7 (24.9) 38.1 (24.5) <0.01
FSH, IU/L 8.4 (6.1) 11.3 (14.3) <0.01







Current smoker, % 48.9 44.8 0.07
HOMA-IR, homeostasis model assessment-insulin resistance; E2, estradiol;
SHBG, sex hormone binding globulin; FSH, follicle-stimulating hormone;
HbA1c, glycated hemoglobin; LH, luteinizing hormone
The data are summarized as the mean (standard deviation) for continuous
variables, or as number with proportion for categorical variables. The Mann–
Whitney U test was used for non-normally distributed continuous variables,
and the Pearson χ2 test was used for dichotomous variables
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was defined as a previous diagnosis by healthcare pro-
fessionals, fasting plasma glucose ≥7.0 mmol/L, or
HbA1c ≥6.5 %. We considered the residence area as a
covariate because in China the prevalence of hypo-
gonadism in rural and urban areas may be different
[15]. The economic development status was measured
by the average gross domestic product per capita of the
entire nation (6807 US dollars, from the World Bank)
in 2013 as the cutoff point for each site.
Statistical analysis
We performed survey analyses using IBM SPSS Statis-
tics, Version 22 (IBM Corporation, Armonk, NY, USA).
All of the analyses were two-sided. P < 0.05 was consid-
ered to be statistically significant. All reported P values
were 2-sided. The general characteristics are summa-
rized as the mean (SD) values for continuous variables
or as a number with proportion for categorical variables.
To test for differences in characteristics between the
participants with and without hypogonadism, and
among 25(OH)D quartiles, Kruskal-Wallis and one-way
ANOVA were used for non-normally and normally dis-
tributed continuous data, respectively, and the Pearson
χ2 test was used for categorical variables. The missing
values of total T (n = 3) and E2 (n = 779) under the min-
imal detectable limit were replaced by the mean values
that were 0.35 nmol/L and 36.7 pmol/L between 0 and
the minimal detectable limit.
The association of 25(OH)D (dependent variable) with
total T, free T, E2, SHBG, FSH and LH (independent var-
iables) was assessed using linear regression. Model 1 was
unadjusted. Model 2 was adjusted for age, residence
area, economic development and current smoker. Model
3 included terms for model 2, BMI, log (HOMA-IR),
diabetes and systolic pressure. Because free T, SHBG,
FSH, LH and HOMA-IR were non-normally distributed,
they were transformed by natural logarithm. The results
were expressed as unstandardized coefficients (B) and
95 % confidence intervals (CIs).
The 25(OH)D was divided into quartiles, with the first
quartile representing the lowest one and the fourth
quartile representing the highest. Odds ratio (OR) and
95 % CI were calculated using logistic regression to de-
termine the risk of hypogonadism for each quartile of
25(OH)D, with the highest quartile as the reference.
Model 1 was adjusted for age, residence area, economic
status and current smoker. Model 2 included terms for
model 1, BMI and HOMA-IR. Model 3 included terms
for model 2, diabetes and systolic pressure.
We tested the interaction effect between 25(OH)D and
residence area, economic status, HbA1c, BMI and
HOMA-IR by adding a multiplicative factor in the logistic
regression model.Results
Characteristics of the study population
General demographic and laboratory characteristics of
the study population are summarized in Table 1. Seven
hundred thirteen (25.0 %) participants had hypogonad-
ism. Among these characteristics, 501 men were diag-
nosed with hypogonadism by total T, 334 men were
diagnosed by free T and 122 men were diagnosed by
both total and free T. Compared to men without hypo-
gonadism, the men with hypogonadism were older and
had significantly lower 25(OH)D levels, higher fasting
insulin levels, HOMA-IR, BMI and systolic pressure as
well as a higher prevalence of diabetes. With regard to
hormones in the pituitary-testis axis, the men with
hypogonadism had significantly lower total T, free T, E2,
SHBG and higher FSH levels.
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lation according to serum 25(OH)D quartiles. The
quartile ranges of 25(OH)D were ≤35.36 nmol/L, 35.37-
41.32 nmol/L, 41.33-48.81 nmol/L and ≥48.82 nmol/L.
Compared with men in the highest quartile, the men in
the lowest quartile were younger and were more likely to
live in an urban area and a rapid economic development
area; however, they had a higher prevalence of hypogonad-
ism and diabetes. These men also had significantly
lower total T, E2, SHBG, FSH and LH levels but higher
free T levels.
Association of 25(OH)D with reproductive hormones
Table 3 summarizes the results of the linear regression
models studying the association of 25(OH)D with total
T, free T, E2, SHBG, LH and FSH. In the unadjusted
models, the higher levels of 25(OH)D were associated
with lower log (free T) (= − 0.002), and higher total T
(B = 0.056), E2 (B = 0.866), log SHBG (B = 0.004), log
LH (B = 0.004) and log FSH (B = 0.005) (all P < 0.001).
After adjustment for age, residence area, economic status
and current smoker, the association of 25(OH)D with logTable 2 Characteristics of the participants by quartiles of 25(OH)D
Q1 Q2
25(OH)D, nmol/L ≤35.36 35.37-41
N 714 715
Age, yr 50 (14) 51 (13)
Hypogonadism, % 28.6 26.0
Metabolic factors
HbA1c, % 5.5 (1.0) 5.4 (0.9)
Fasting glucose, mmol/L 5.68 (1.51) 5.63 (1.4
Fasting insulin, pmol/L 42.2 (48.5) 40.8 (38
HOMA-IR 1.60 (2.33) 1.53 (1.8
Systolic pressure, mmHg 132 (19) 131 (20)
BMI, kg/m2 24.3 (3.3) 24.9 (3.5
Diabetes, % 14.7 11.5
Sex-related hormones
Total T, nmol/L 15.5 (5.7) 15.8 (5.7
Free T, pmol/L 50.6 (29.0) 51.1 (33
E2, pmol/L 99.9 (59.2) 101.5 (5
SHBG, nmol/L 42.4 (23.4) 41.8 (22
FSH, IU/L 8.1 (7.5) 8.2 (6.6)
LH, IU/L 5.0 (3.9) 5.1 (3.5)
Rural/urban residence, % 51.1/48.9 49.0/51.
Economic status, {low/high, %} 17.9/82.1 27.6/72.
Current smoker, % 50.7 50.4
HOMA-IR, homeostasis model assessment-insulin resistance; T, testosterone; E2, estr
HbA1c, glycated hemoglobin; LH, luteinizing hormone
The data are summarized as the mean (standard deviation) for continuous variables
was used for non-normally distributed continuous variables, and the Pearson χ2 tes(free T) weakened further to the extent that it was no
longer significant. After additional adjustments for
BMI, HOMA-IR, diabetes and systolic pressure, only
total T (B = 0.023) and E2 (B = 0.238) were still associated
with 25(OH)D (both P < 0.05).
Association of 25(OH)D with hypogonadism
Table 4 demonstrates the results of the binary logistic
regression measuring the association of 25(OH)D status
with hypogonadism. In all of the models, the odds ra-
tios for hypogonadism decreased across 25(OH)D quar-
tiles (all P for trend <0.01). Compared with men in the
highest quartile of 25(OH)D (Table 4, model 1), the
odds ratio of hypogonadism in men in the lowest quar-
tile of 25(OH)D were 1.54 (95 % CI, 1.19, 2.01; P <
0.01). After adjustments for BMI and HOMA-IR, the
association was so weakened (Table 4, model 2) that it
was no longer significant in Q2. Additional adjustment
for diabetes and systolic blood pressure did not weaken
this association (Table 4, model 3). No interaction was
observed between 25(OH)D, and diabetes, BMI and
HOMA-IR.Q3 Q4
.32 41.33-48.81 ≥48.82 P
712 713
53 (13) 59 (13) <0.01
22.8 22.6 <0.05
5.4 (0.9) 5.5 (0.9) <0.05
5) 5.68 (1.31) 5.71 (1.34) <0.05
.0) 37.3 (32.5) 35.3 (45.1) <0.01
1) 1.41 (1.50) 1.34 (1.94) <0.01
130 (19) 135 (21) <0.01
) 24.6 (3.1) 24.2 (3.2) <0.01
13.4 12.5 0.31
) 16.2 (5.7) 17.1 (6.1) <0.01
.9) 49.0 (26.4) 44.4 (23.0) <0.01
9.8) 106.0 (61.3) 121.9 (69.5) <0.01
.4) 45.2 (23.7) 54.8 (28.7) <0.01
8.6 (6.8) 11.4 (13.0) <0.01
5.2 (2.8) 6.6 (5.4) <0.01
0 53.5/46.5 73.2/26.8 <0.01
4 30.8/69.2 32.8/67.2 <0.01
46.2 44.0 <0.05
adiol; SHBG, sex hormone binding globulin; FSH, follicle-stimulating hormone;
, or as number with proportion for categorical variables. The Kruskal-Wallis test
t was used for dichotomous variables
Table 3 Association of 25(OH)D with sex-related hormones
25(OH)D, nmol/L
Dependent variables Model 1 Model 2 Model 3
Total T, nmol/L 0.056 (0.038, 0.074)*** 0.031 (0.011, 0.051)** 0.023 (0.004, 0.042)*
Log (free T), pmol/L −0.002 (−0.003, −0.001)*** −0.001 (−0.001, 0.000) −0.001 (−0.001, 0.000)
E2, pmol/L 0.866 (0.671, 1.061)*** 0.264 (0.054, 0.475)* 0.238 (0.023, 0.452)*
Log SHBG, nmol/L 0.004 (0.004, 0.005)*** 0.001 (0.000, 0.002)** 0.001 (0.000, 0.001)
Log LH, IU/L 0.004 (0.003, 0.004)*** 0.001 (0.000, 0.001)* 0.001 (0.000, 0.001)
Log FSH, IU/L 0.005 (0.004, 0.006)*** 0.001 (0.000, 0.002)* 0.001 (0.000, 0.002)
The data are expressed as B coefficient (95 % confidence interval)
T, testosterone; E2, estradiol; SHBG, sex hormone binding globulin
Model 1 was unadjusted. Model 2 included terms for age, residence area, economic status and current smoker. Model 3 included terms for model 2, BMI, log
(HOMA-IR), diabetes and systolic pressure. To obtain the average percentage change in free T, SHBG, LH or FSH from log hormone = 100 × (exp(B coefficient) - 1)
*P < 0.05, **P < 0.01, ***P < 0.001. Linear regression analysis was used
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In this population-based study of middle-aged and older
Chinese men, we observed that lower 25(OH)D level
was significantly associated with lower total T, E2,
SHBG, LH and FSH levels after adjusting for age, resi-
dence area, economic status and current smoker. Add-
itional adjustments for BMI, HOMA-IR, diabetes and
systolic pressure revealed that total T and E2 were still
associated with 25(OH)D. The fully adjusted odds ratio
of hypogonadism increased by 50 % for the lowest quar-
tile compared with the highest quartile of 25(OH)D. Adi-
posity and insulin resistance may, in part, explain this
association. To the best of our knowledge, this study is
the first to detect the association between 25(OH)D
status and hypogonadism in Chinese men and confirms
that this relationship is present in a large population.
Vitamin D deficiency, which affects not only the muscu-
loskeletal system but also a number of acute and chronic
diseases, is currently a pandemic health problem. In 1711
healthy Caucasian adults, the mean serum vitamin D con-
centration was 64.4 nmol/L in men [16]. In 136 healthy
Japanese males, the median 25(OH)D concentration was
36.5 nmol/L and approximately 75 % of the subjects had
25(OH)D-deficiency (25(OH)D <50 nmol/L) [17]. In
our participants, the fourth quartile of 25(OH)D wasTable 4 Association of 25(OH)D with hypogonadism
25(OH)D, nmol/L Model 1 Model 2 Model 3
Q1 (≤35.36) 1.54 (1.19, 2.01) 1.49 (1.14, 1.95) 1.50 (1.14, 1.97)
Q2 (35.37-41.32) 1.38 (1.06, 1.80) 1.26 (0.96, 1.66) 1.27 (0.97, 1.67)
Q3 (41.33-48.81) 1.07 (0.82, 1.40) 1.04 (0.79, 1.36) 1.03 (0.79, 1.36)
Q4 (≥48.82) 1.00 1.00 1.00
P value for trend <0.01 <0.01 <0.01
The data are expressed as odds ratio (95 % CI) unless otherwise indicated.
Logistic regression analysis was used
Model 1 included terms for age, residence area, economic status, and current
smoker. Model 2 included terms for model 1, BMI, and HOMA-IR. Model 3
included terms for model 2, diabetes, and systolic pressure. No interaction
was found between 25(OH)D, and BMI and HOMA-IR48.82 nmol/L, so at least 75 % had suboptimal
25(OH)D. Interestingly, serum 25(OH)D was higher in
older men than in younger men. This finding may be
due to more indoor and sedentary activities in the
young, whereas the older, retired men may engage in
more outdoor activities that result in more sun expos-
ure; this result warrants additional investigation.
Our results demonstrating an association of vitamin D
status and testosterone in men are also consistent with
outcomes in animal studies. VDR knockout mutant mice
showed gonadal insufficiencies. High LH and FSH levels in
the male mice indicated hypergonadotropic hypogonadism
[18]. Another mouse study reported a tendency towards
low testosterone/LH ratio and Leydig cell hyperplasia in
VDR null mice [19]. The serum testosterone levels could
increase to normal values in vitamin D-deficient rats re-
plete with vitamin D [20]. However, controversy exists re-
garding to what extent vitamin D is important for sex
hormone production. Blomberg Jensen et al. found that
testosterone and LH serum levels were not significantly
different between wildtype and VDRnull mice [19]. Add-
itionally, vitamin D may also regulate reproductive func-
tion. VDR knockout mice had decreased sperm count,
reduced sperm motility, and histological abnormality of the
testis [18]. Pilz et al. [21] reported that vitamin D supple-
mentation increases testosterone levels in non-diabetic
subjects, although Jorde et al. [22] could not detect an ef-
fect of vitamin D supplements on serum testosterone con-
centrations in healthy men.
Our results are consistent with three previous popula-
tion-based reports [1, 10, 14]. The data from the European
Male Ageing Study [9] indicated that 25(OH)D is posi-
tively associated with total T. However, after adjusting for
health and lifestyle factors, no significant associations were
observed. This study recruited non-institutionalized, pri-
marily Caucasian men, and the data may, therefore, not be
generalizable to other groups. The association of 25(OH)D
with free T varied [1, 9, 10, 14]. Because of the strong
inter- and intra-assay coefficients of variation of free T
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should be viewed with caution [10].
In our study, hypogonadism was defined as total
T <11.3 nmol/L or free T < 22.56 pmol/L, and the preva-
lence of hypogonadism was 25.0 % among our participants
with a mean age of 53 years. In the Hypogonadism in
Males study in the USA, the prevalence of hypogonadism
was 38.7 % in men aged ≥45 years [23] and in Taiwanese
men aged >40 years; 24.1 % had androgen deficiency [24],
both of which were based on total T. Our prevalence
seemed to be comparable with that observed in Taiwanese
men. Such a high prevalence of hypogonadism was found
to be associated with pandemic vitamin D deficiency in
our study. Our results included the evidence from a new
ethnic group reported in previous studies [1, 9, 10, 14].
We observed that adjustments for BMI and HOMA-IR
attenuated the association between vitamin D and
hypogonadism, indicating that this association was in
part explained by adiposity and insulin resistance. The
association between obesity and hypogonadism has been
well researched [25]. Previous studies have reported that
obesity is associated with low serum 25(OH)D levels [26].
Vitamin D may regulate adipose tissue [27]. VDR is ob-
served in human adipocytes [28], and vitamin D deficiency
is capable of up-regulating parathyroid hormone, thereby
increasing free intracellular calcium in adipocytes, which
blunts the lipolytic response to catecholamines and en-
hances lipogenesis [29]. Thus, this association may, in
part, be mediated through adiposity.
Our study had several strengths. First, regarding the
significance, this study is the first to detect the associ-
ation between 25(OH)D status and hypogonadism in
general Chinese men, the largest population group in
the world, thereby adding new evidence to previous re-
search. Second, this study has strong quality control; the
anthropometric measurements and questionnaires were
all completed by the same trained research group, and
all of the biomedical measurements were performed in
one laboratory certified by the College of American Pa-
thologists. Third, our results are more reflective because
the SPECT-China study was performed in a general
population as opposed to a clinic-based population.
However, our study has several limitations. First, due to
the cross-sectional nature of the study, we cannot draw
a causal relationship between 25(OH)D status and hypo-
gonadism. Second, this study recruited primarily Han
Chinese men and the data cannot be generalizable to
other ethnic groups. Third, we measured reproductive
hormones and vitamin D once, indicating that we could
not perform the seasonal variation analysis.
Conclusions
Vitamin D deficiency is pandemic in Chinese men. Lower
vitamin D levels were associated with a higher prevalenceof hypogonadism in Chinese men. This association was, in
part, explained by adiposity and insulin resistance, which
warrants additional investigation.
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